We hypothesized that overweight and obese women at
risk for GDM will benefit from MVPA and that in this
group of women there is a favorable relationship between
objectively measured time spent in MVPA and maternal
glucose, insulin sensitivity, and glycosylated hemoglobin
(HbA1c) at different time points in pregnancy.